These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 10919685)
1. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group. Ayres JG; Millar AB; Sykes AP Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group. Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group. Perruchoud AP; Lundback B; Yigla M; Sykes AP Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684 [TBL] [Abstract][Full Text] [Related]
4. Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group. Salat D; Popov D; Sykes AP Respir Med; 2000 Jun; 94 Suppl B():S22-8. PubMed ID: 10919682 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma. Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480 [TBL] [Abstract][Full Text] [Related]
6. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group. Baumgarten CR; Dorow P; Weber HH; Gebhardt R; Kettner J; Sykes AP Respir Med; 2000 Jun; 94 Suppl B():S17-21. PubMed ID: 10919681 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children. Lyttle B; Gilles J; Panov M; Emeryk A; Wixon C Can Respir J; 2003 Mar; 10(2):103-9. PubMed ID: 12687029 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma. Aubier M; Wettenger R; Gans SJ Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239 [TBL] [Abstract][Full Text] [Related]
12. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma. Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M; Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603 [TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group. Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425 [TBL] [Abstract][Full Text] [Related]
14. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics. Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526 [TBL] [Abstract][Full Text] [Related]
15. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness. Langley SJ; Holden J; Derham A; Hedgeland P; Sharma RK; Woodcock A Chest; 2002 Sep; 122(3):806-11. PubMed ID: 12226017 [TBL] [Abstract][Full Text] [Related]
16. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant. Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507 [TBL] [Abstract][Full Text] [Related]
17. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
20. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC. Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]